Literature DB >> 2737183

Increased chromosome fragility as a consequence of blood folate levels, smoking status, and coffee consumption.

A T Chen1, J A Reidy, J L Annest, T K Welty, H G Zhou.   

Abstract

Chromosome fragility in 96 h, low-folate cultures was found to be associated with smoking status, coffee consumption, and blood folate level. The higher proportion of cells with chromosome aberrations in cigarette smokers was attributable to lower red cell folate levels in smokers compared with nonsmokers. There was a positive linear relationship between the average cups of coffee consumed per day and the proportion of cells with aberrations. This association was independent of the effects of smoking and red cell folate level. These data suggest that smoking history, coffee consumption, and red cell folate level are important considerations for the design and interpretation of fragile site studies in cancer cytogenetics.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2737183     DOI: 10.1002/em.2850130407

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  8 in total

1.  Population cytogenetics of aphidicolin-induced fragile sites.

Authors:  B Tedeschi; P Vernole; M L Sanna; B Nicoletti
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

2.  Cytogenetic damage induced by folate deficiency in mice is enhanced by caffeine.

Authors:  J T MacGregor; R Schlegel; C M Wehr; P Alperin; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 3.  Folate in skin cancer prevention.

Authors:  J D Williams; Elaine L Jacobson; H Kim; M Kim; M K Jacobson
Journal:  Subcell Biochem       Date:  2012

4.  Interventional study of high dose folic acid in gastric carcinogenesis in beagles.

Authors:  S D Xiao; X J Meng; Y Shi; Y B Hu; S S Zhu; C W Wang
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

5.  Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer.

Authors:  Dong-Hyun Kim; Stephanie A Smith-Warner; Donna Spiegelman; Shiaw-Shyuan Yaun; Graham A Colditz; Jo L Freudenheim; Edward Giovannucci; R Alexandra Goldbohm; Saxon Graham; Lisa Harnack; Eric J Jacobs; Michael Leitzmann; Satu Mannisto; Anthony B Miller; John D Potter; Thomas E Rohan; Arthur Schatzkin; Frank E Speizer; Victoria L Stevens; Rachael Stolzenberg-Solomon; Paul Terry; Paolo Toniolo; Matty P Weijenberg; Walter C Willett; Alicja Wolk; Anne Zeleniuch-Jacquotte; David J Hunter
Journal:  Cancer Causes Control       Date:  2010-09-05       Impact factor: 2.506

6.  Methylenetetrahydrofolate reductase polymorphisms and interaction with smoking and alcohol consumption in lung cancer risk: a case-control study in a Japanese population.

Authors:  Chikako Kiyohara; Takahiko Horiuchi; Koichi Takayama; Yoichi Nakanishi
Journal:  BMC Cancer       Date:  2011-10-25       Impact factor: 4.430

7.  Folate levels modulate oncogene-induced replication stress and tumorigenicity.

Authors:  Noa Lamm; Karin Maoz; Assaf C Bester; Michael M Im; Donna S Shewach; Rotem Karni; Batsheva Kerem
Journal:  EMBO Mol Med       Date:  2015-09       Impact factor: 12.137

8.  One-carbon metabolism biomarkers and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition.

Authors:  Alina Vrieling; H Bas Bueno-De-Mesquita; Martine M Ros; Ellen Kampman; Katja K Aben; Frederike L Büchner; Eugène H Jansen; Nina Roswall; Anne Tjønneland; Marie-Christine Boutron-Ruault; Claire Cadeau; Jenny Chang-Claude; Rudolf Kaaks; Steffen Weikert; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Sabina Sieri; Domenico Palli; Salvatore Panico; Petra H Peeters; Elisabete Weiderpass; Guri Skeie; Paula Jakszyn; María-Dolores Chirlaque; Eva Ardanaz; María-José Sánchez; Roy Ehrnström; Johan Malm; Börje Ljungberg; Kay-Tee Khaw; Nick J Wareham; Paul Brennan; Mattias Johansson; Elio Riboli; Lambertus A Kiemeney
Journal:  Int J Cancer       Date:  2019-02-13       Impact factor: 7.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.